Impact Factor 2019: 1.940 (@Clarivate Analytics)
5-Year Impact Factor: 1.955 (@Clarivate Analytics)
  • Users Online: 174
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

The 2019 novel coronavirus disease (COVID-19) pandemic: A zoonotic prospective

Chakraborty Chiranjib, Sharma Ashish Ranjan, Bhattacharya Manojit, Sharma Garima, Lee Sang-Soo

Year : 2020| Volume: 13| Issue : 6 | Page no: 242-246

   This article has been cited by
 
1 Repurposing of the Herbals as Immune-Boosters in the Prevention and Management of COVID-19: A Review
Rinki Kumari,Anita Venaik,Md Al Hasibuzzaman,Simon Agongo Azure,Rudra P. Ojha,Ajay Kumar Sahi
Journal of Pure and Applied Microbiology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis
Masoumeh Adhami,Balal Sadeghi,Ali Rezapour,Ali Akbar Haghdoost,Habib MotieGhader
BMC Biotechnology. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
3 Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines
José Adão Carvalho Nascimento Júnior,Anamaria Mendonça Santos,Rafael Ciro Marques Cavalcante,Lucindo José Quintans-Júnior,Cristiani Isabel Banderó Walker,Lysandro Pinto Borges,Luiza Abrahão Frank,Mairim Russo Serafini
Drug Development and Industrial Pharmacy. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? – A computational approach
Thomas Scior,Hassan H. Abdallah,Siti Fatimah Zaharah Mustafa,José Antonio Guevara-García,Dieter Rehder
Inorganica Chimica Acta. 2021; 519: 120287
[Pubmed]  [Google Scholar] [DOI]
5 Diagnosis For COVID-19: Current Status and Future Prospects
Alamgir Kabir,Rajib Ahmed,Sheikh Muhammad Asher Iqbal,Rasheduzzaman Chowdhury,Ramasamy Paulmurugan,Utkan Demirci,Waseem Asghar
Expert Review of Molecular Diagnostics. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review
Nidhi Chauhan,Shringika Soni,Abhinandan Gupta,Mohammad Aslam,Utkarsh Jain
Journal of Medical Virology. 2021; 93(4): 1967
[Pubmed]  [Google Scholar] [DOI]
7 Response to: Status of Remdesivir: Not Yet Beyond Question!
Abinit Saha,Ashish Ranjan Sharma,Manojit Bhattacharya,Garima Sharma,Sang-Soo Lee,Chiranjib Chakraborty
Archives of Medical Research. 2021; 52(1): 104
[Pubmed]  [Google Scholar] [DOI]
8 A survey on COVID-19 vaccine acceptance and concern among Malaysians
S. A. R. Syed Alwi,E. Rafidah,A. Zurraini,O. Juslina,I. B. Brohi,S. Lukas
BMC Public Health. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
9 A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics
Jyoti Verma,Naidu Subbarao
Archives of Virology. 2021;
[Pubmed]  [Google Scholar] [DOI]
10 Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
Seyed Mehdi Sadat,Mohammad Reza Aghadadeghi,Masoume Yousefi,Arezoo Khodaei,Mona Sadat Larijani,Golnaz Bahramali
Molecular Biotechnology. 2021;
[Pubmed]  [Google Scholar] [DOI]
11 Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature
Juan Lu,Zhong-Yang Xie,Dan-Hua Zhu,Lan-Juan Li
World Journal of Clinical Cases. 2021; 9(7): 1705
[Pubmed]  [Google Scholar] [DOI]
12 Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
Ratnadeep Saha,Pratik Ghosh,V. L. S. Prasad Burra
3 Biotech. 2021; 11(2)
[Pubmed]  [Google Scholar] [DOI]
13 SARS-CoV-2 and other human coronavirus: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
Chiranjib Chakraborty,Ashish Ranjan Sharma,Manojit Bhattacharya,Rudra P. Saha,Sanmitra Ghosh,Soham Biswas,Saikat Samanta,Garima Sharma,Govindasamy Agoramoorthy,Sang-Soo Lee
Infection, Genetics and Evolution. 2021; : 104729
[Pubmed]  [Google Scholar] [DOI]
14 Efficacy and Safety of Pegylated Interferon alfa-2b in Moderate COVID-19: A phase II, randomized, controlled, open-label study
Anuja Pandit,Nirav Bhalani,B.L. Shashi Bhushan,Parshottam Koradia,Shweta Gargiya,Vinay Bhomia,Kevinkumar Kansagra
International Journal of Infectious Diseases. 2021;
[Pubmed]  [Google Scholar] [DOI]
15 Reported quality of life in countries with cases of COVID19: a systematic review
Maria Eduarda Melo-Oliveira,Danúbia Sá-Caputo,José Alexandre Bachur,Laisa Liane Paineiras-Domingos,Anelise Sonza,Ana Cristina Lacerda,Vanessa Mendonça,Adérito Seixas,Redha Taiar,Mario Bernardo-Filho
Expert Review of Respiratory Medicine. 2021; 15(2): 213
[Pubmed]  [Google Scholar] [DOI]
16 Challenges faced in establishing a dedicated 250 bed COVID-19 intensive care unit in a temporary structure
Shalendra Singh,George Cherian Ambooken,Rangraj Setlur,Shamik Kr Paul,Madhuri Kanitkar,Surinder Singh Bhatia,Ratnesh Singh Kanwar
Trends in Anaesthesia and Critical Care. 2021; 36: 9
[Pubmed]  [Google Scholar] [DOI]
17 Covid-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India
Dibya Sundar Panda,Ranjan Kumar Giri,Anil Kumar Nagarajappa,Sakeenabi Basha
Human Vaccines & Immunotherapeutics. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
18 Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
Xianfang Tang,Lijun Cai,Yajie Meng,JunLin Xu,Changcheng Lu,Jialiang Yang
Frontiers in Immunology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
19 SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development
Chiranjib Chakraborty,Manojit Bhattacharya,Bidyut Mallick,Ashish Ranjan Sharma,Sang-Soo Lee,Govindasamy Agoramoorthy
Expert Review of Clinical Pharmacology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
20 Simulink Modelling For Simulating Intensive Care Mechanical Ventilators
Paolo Tamburrano,Pietro De Palma,Andrew R. Plummer,Elia Distaso,Riccardo Amirante
E3S Web of Conferences. 2020; 197: 07007
[Pubmed]  [Google Scholar] [DOI]
21 Covid-19: a comprehensive review of a formidable foe and the road ahead
Arafat Hussain,Suniti Yadav,Vijay Hadda,Tejas M Suri,Pawan Tiwari,Saurabh Mittal,Karan Madan,Anant Mohan
Expert Review of Respiratory Medicine. 2020; 14(9): 869
[Pubmed]  [Google Scholar] [DOI]
22 Ten challenging questions about SARS-CoV-2 and COVID-19
Majid Teymoori-Rad,Saeed Samadizadeh,Alijan Tabarraei,Abdolvahab Moradi,Mahsa Bataghva Shahbaz,Alireza Tahamtan
Expert Review of Respiratory Medicine. 2020; 14(9): 881
[Pubmed]  [Google Scholar] [DOI]
23 Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach
Samira Sanami,Milad Zandi,Behzad Pourhossein,Gholam-Reza Mobini,Mohsen Safaei,Atena Abed,Pooria Mohammadi Arvejeh,Fatemeh Amini Chermahini,Morteza Alizadeh
International Journal of Biological Macromolecules. 2020; 164: 871
[Pubmed]  [Google Scholar] [DOI]
24 Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
Hong-Zhi Chen,Ling-Li Tang,Xin-Ling Yu,Jie Zhou,Yun-Feng Chang,Xiang Wu
Infectious Diseases of Poverty. 2020; 9(1)
[Pubmed]  [Google Scholar] [DOI]
25 Understanding COVID-19: From Origin to Potential Therapeutics
Muhammad Moazzam,Muhammad Imran Sajid,Hamza Shahid,Jahanzaib Butt,Irfan Bashir,Muhammad Jamshaid,Amir Nasrolahi Shirazi,Rakesh Kumar Tiwari
International Journal of Environmental Research and Public Health. 2020; 17(16): 5904
[Pubmed]  [Google Scholar] [DOI]
26 Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
José María Díez,Carolina Romero,Júlia Vergara-Alert,Melissa Belló-Perez,Jordi Rodon,José Manuel Honrubia,Joaquim Segalés,Isabel Sola,Luis Enjuanes,Rodrigo Gajardo
Immunotherapy. 2020; 12(17): 1247
[Pubmed]  [Google Scholar] [DOI]
27 Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection
Soumya Ranjan Mahapatra,Susrita Sahoo,Budheswar Dehury,Vishakha Raina,Shubhransu Patro,Namrata Misra,Mrutyunjay Suar
Expert Review of Vaccines. 2020; 19(9): 871
[Pubmed]  [Google Scholar] [DOI]
28 Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework
Neeraj Kumar,Damini Sood,Ramesh Chandra
RSC Advances. 2020; 10(59): 35856
[Pubmed]  [Google Scholar] [DOI]
29 Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Federica Mannino,Alessandra Bitto,Natasha Irrera
Frontiers in Pharmacology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
30 Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex
Manojit Bhattacharya,Ashish Ranjan Sharma,Bidyut Mallick,Garima Sharma,Sang-Soo Lee,Chiranjib Chakraborty
Infection, Genetics and Evolution. 2020; 85: 104587
[Pubmed]  [Google Scholar] [DOI]
31

Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey

Mohammed Al-Mohaithef,Bijaya Kumar Padhi
Journal of Multidisciplinary Healthcare. 2020; Volume 13: 1657
[Pubmed]  [Google Scholar] [DOI]
32 In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury,Suprabhat Mukherjee
Journal of Medical Virology. 2020; 92(10): 2105
[Pubmed]  [Google Scholar] [DOI]
33 TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
Mohammad Azam Ansari,Qazi Mohammad Sajid Jamal,Suriya Rehman,Ahmad Almatroudi,Mohammad A. Alzohairy,Mohammad N. Alomary,Takshashila Tripathi,Ali H. Alharbi,Syed Farooq Adil,Mujeeb Khan,M. Shaheer Malik
Arabian Journal of Chemistry. 2020; 13(11): 8069
[Pubmed]  [Google Scholar] [DOI]

 

Read this article